Dr. Denise A. Yardley, MONALEESA-2 Investigator, Breast Cancer Research Program, Sarah Cannon Research Institute and Shirley A. Mertz, Presi
Jan 27, 2022 ·
11m 27s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
According to The American Cancer Society, Metastatic breast cancer (mBC) is the most serious form of the disease and takes a life in the United States approximately every 12 minutes...
show more
According to The American Cancer Society, Metastatic breast cancer (mBC) is the most serious form of the disease and takes a life in the United States approximately every 12 minutes creating an urgent need for treatment proven to extend life while preserving quality of life. My guests, Dr. Denise A. Yardley, a MONALEESA-2 Investigator, Breast Cancer Research Program, Sarah Cannon Research Institute and Shirley A. Mertz, President, Metastatic Breast Cancer Network, join me with the updated results of a targeted treatment from the Monaleesa-2 trial.
show less
Information
| Author | BizTalkPodcasts |
| Organization | BizTalkPodcasts |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
